Detalhe da pesquisa
1.
MRP3-Mediated Chemoresistance in Cholangiocarcinoma: Target for Chemosensitization Through Restoring SOX17 Expression.
Hepatology
; 72(3): 949-964, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31863486
2.
Causes of hOCT1-Dependent Cholangiocarcinoma Resistance to Sorafenib and Sensitization by Tumor-Selective Gene Therapy.
Hepatology
; 70(4): 1246-1261, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30972782
3.
Impact of alternative splicing on cholangiocarcinoma progression through metabolic rewiring-induced epigenetic events.
J Hepatol
; 2024 May 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38810883
4.
Signalling networks in cholangiocarcinoma: Molecular pathogenesis, targeted therapies and drug resistance.
Liver Int
; 39 Suppl 1: 43-62, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30903728
5.
Chemosensitization of hepatocellular carcinoma cells to sorafenib by ß-caryophyllene oxide-induced inhibition of ABC export pumps.
Arch Toxicol
; 93(3): 623-634, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30659321
6.
Role of the placenta in serum autotaxin elevation during maternal cholestasis.
Am J Physiol Gastrointest Liver Physiol
; 315(3): G399-G407, 2018 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29927323
7.
The search for novel diagnostic and prognostic biomarkers in cholangiocarcinoma.
Biochim Biophys Acta Mol Basis Dis
; 1864(4 Pt B): 1468-1477, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28782657
8.
Chemoresistance and chemosensitization in cholangiocarcinoma.
Biochim Biophys Acta Mol Basis Dis
; 1864(4 Pt B): 1444-1453, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28600147
9.
SOX17 regulates cholangiocyte differentiation and acts as a tumor suppressor in cholangiocarcinoma.
J Hepatol
; 67(1): 72-83, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28237397
10.
Inhibition of metalloprotease hyperactivity in cystic cholangiocytes halts the development of polycystic liver diseases.
Gut
; 63(10): 1658-67, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24436140
11.
Expression of SLC22A1 variants may affect the response of hepatocellular carcinoma and cholangiocarcinoma to sorafenib.
Hepatology
; 58(3): 1065-73, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23532667
12.
Liver metabolic/oxidative stress induces hepatic and extrahepatic changes in the expression of the vitamin C transporters SVCT1 and SVCT2.
Eur J Nutr
; 53(2): 401-12, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-23708151
13.
Sensitization of cholangiocarcinoma cells to chemotherapy through BCRP inhibition with ß-caryophyllene oxide.
Biomed Pharmacother
; 170: 116038, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38141281
14.
Evaluation of potential targets to enhance the sensitivity of cholangiocarcinoma cells to anticancer drugs.
Biomed Pharmacother
; 168: 115658, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37832404
15.
Relevance of the organic anion transporting polypeptide 1B3 (OATP1B3) in the personalized pharmacological treatment of hepatocellular carcinoma.
Biochem Pharmacol
; 214: 115681, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37429423
16.
Impact of Aberrant ß-Catenin Pathway on Cholangiocarcinoma Heterogeneity.
Cells
; 12(8)2023 04 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37190050
17.
Impact of alternative splicing on mechanisms of resistance to anticancer drugs.
Biochem Pharmacol
; 193: 114810, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34673012
18.
Impact of Alternative Splicing Variants on Liver Cancer Biology.
Cancers (Basel)
; 14(1)2021 Dec 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35008179
19.
Association of FOXO3 Expression with Tumor Pathogenesis, Prognosis and Clinicopathological Features in Hepatocellular Carcinoma: A Systematic Review with Meta-Analysis.
Cancers (Basel)
; 13(21)2021 Oct 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-34771514
20.
Plasma Membrane Transporters as Biomarkers and Molecular Targets in Cholangiocarcinoma.
Cells
; 9(2)2020 02 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-32098199